A study by researchers at Columbia University Vagelos College of Physicians and Surgeons has found that new cutting-edge ...
Prime editing holds tremendous promise for precise genome engineering, but achieving efficient editing without increasing pegRNA complexity remains a significant challenge. Join this webinar to ...
InvestorsHub on MSN
Cellectis announces in vivo gene editing transformation, exits lasme-cel and eti-cel development
Cellectis is shifting its development strategy toward in vivo gene editing after reporting preclinical proof-of-concept for ...
mFLUSIVA becomes Moderna's fifth approved product globally and fourth FDA-approved product Company expects supply to be available ... · ACCESS Newswire · Moderna, Inc. The above button links to ...
Editas Medicine reports advancements in in vivo gene editing, financial results, and plans for upcoming development candidates by mid-2025. Editas Medicine, Inc. announced its progress in developing ...
Scientists at the University of California, Santa Cruz (UCSC), used CRISPR to engineer cellular models of embryos that mimic what happens in the first few days after reproductive cells meet. These ...
Cibus, Inc. announced significant advancements in its gene editing technology, particularly the establishment of production standards for its proprietary RTDS gene editing system, which enables the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results